Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer02:18

Cancer

54.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same author

Contrast-enhanced MRI improves the diagnostic performance for vaginal fornix invasion in cervical carcinoma.

Insights into imaging·2026
Same author

Stimuli-responsive copper-iodide nanoparticles for low-dose X-ray-induced photodynamic therapy and enhanced cuproptosis.

Acta biomaterialia·2026
Same author

Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation.

BMC cancer·2025
Same author

Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.

Nature communications·2025
Same journal

Can nanozymes achieve more than enzymes?

Nature reviews. Materials·2026
Same journal

Delivering living medicines with biomaterials.

Nature reviews. Materials·2026
Same journal

Materials Advances for Distributed Environmental Sensor Networks at Scale.

Nature reviews. Materials·2026
Same journal

Atomically thin bioelectronics.

Nature reviews. Materials·2025
Same journal

Ingestible Electronics for Diagnostics and Therapy.

Nature reviews. Materials·2025
Same journal

Materials and device strategies to enhance spatiotemporal resolution in bioelectronics.

Nature reviews. Materials·2025
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.7K

Rethinking cancer nanotheranostics.

Hongmin Chen1,2,3, Weizhong Zhang2, Guizhi Zhu4

  • 1Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China.

Nature Reviews. Materials
|October 28, 2017
PubMed
Summary
This summary is machine-generated.

Nanotheranostics, combining diagnosis and therapy using nanoparticles, offers advanced cancer management solutions. This approach enables personalized treatments, improved monitoring, and better patient outcomes in clinical settings.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.7K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Area of Science:

  • Biomedical Engineering
  • Nanomedicine
  • Oncology

Background:

  • Nanotheranostics integrate diagnostic and therapeutic functions at the nanoscale.
  • The field has significant applications in cancer management, including patient stratification and treatment monitoring.

Purpose of the Study:

  • To review the evolution and current state of cancer nanotheranostics.
  • To highlight the clinical impact and translational aspects of nanotheranostics in oncology.

Main Methods:

  • Review of recent advances in nanoparticle synthesis and engineering for nanotheranostics.
  • Analysis of clinical applications and translational progress in cancer nanotheranostics.

Main Results:

  • Nanotheranostics enable individualized cancer characterization and treatment design.
  • The concept of nanotheranostics is evolving beyond single-entity agents to interwoven diagnostic and therapeutic approaches.

Conclusions:

  • Nanotheranostics represent a significant advancement in personalized cancer care.
  • The integrated approach of nanotheranostics holds promise for improving treatment outcomes and clinical translation.